Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has informed the stock exchanges about an upcoming one-on-one meeting with institutional investors scheduled for August 20, 2025. The meeting will take place at the Antique Flagship Investor Conference 2025 in Mumbai and will be conducted physically. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be shared during the meeting. The schedule is subject to change based on exigencies on the part of the investor or the company.
This is a routine regulatory disclosure about a scheduled investor engagement and is unlikely to have any direct impact on the stock price. It signals continued institutional investor outreach by the company, which is standard practice for listed firms.